← BackInteger Holdings Corp · Electromedical & Electrotherapeutic ApparatusITGR
Low riskNext report: Due any day
The short versionA profitable company with steady sales.
Going well
- Profitable every year for 10 years
- Brings in more cash than it spends
Money moves
- No insider buying or selling in the last 30 days
- Institutions added 4.4% to their holdings in the quarter ending June 2026 (145 bought, 160 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$126.550.0% that day
- Company value
- $4.3B
- Share price times all shares
- Price vs profit (P/E)
- 34.7x
- You pay about $35 for each $1 of yearly profit
- Price vs sales
- 2.3x
- Company value is 2.3 times a year of sales
- Cash vs value
- 0%
- Cash as a share of company value
- Debt vs value
- 28%
- Debt as a share of company value
From ITGR's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jul '26$464.1M-2.6% vs a year earlier
Sep '23Tap a barJul '26
Last 12 months: $1.8B, up 2.7% from the 12 months before. Over 5 years, sales grew about 12% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- MissReturn on equity 15%+Earns a lot on the money owners have in the business.6.1%
- MissDebt under half of equityNot relying on borrowed money.0.68x equity
- MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.5.5%
- PassProfitable every yearSteady profits, not one good year.10 of 10 years
- PassFree cash flow positiveBrings in more cash than it spends to run and grow.$105.1M
- MissShare count not growingNot diluting owners. Falling means buybacks.+6.7% in 3 years
- MissGross margin 40%+Pricing power: sells for well above what it costs to make.27.0%
- Revenue
- $1.9B
- +8.0% vs prior year
- 5-year growth
- +11.5%/yr
- revenue, per year
- Total debt
- $1.2B
- 0.68x equity
- Current ratio
- 3.32x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jul 3, 2026- Revenue
- $464.1M
- -2.6% YoY
- EPS
- $0.69
- vs $1.04
- Op. margin
- 7.4%
- -5.1 pts
- Gross margin
- 24.3%
- -2.8 pts
- Free cash flow
- $37.0M
- Share count
- -4.4%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
48/ 100
- This week
- 2
- Normal week
- 2.2
- vs normal
- 0.9x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
■Steady+4.4%Institutions added 4.4% to their holdings. 145 bought, 160 sold. 2 quarters of net buying in a row.
Shares held by institutions40.9M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
+0.7%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
0.7x · $1.2B debtShares outstandingLatest reported
34MNext reportDue any dayEstimated from the same quarter last year
- Results filedAug 3
- Results filedApr 30
- Results filedFeb 19
- Results filedOct 23, 2025
- Results filedJul 24, 2025
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.